Back to Search Start Over

Paediatric Home Artificial Nutrition in Italy: Report from 2016 Survey on Behalf of Artificial Nutrition Network of Italian Society for Gastroenterology, Hepatology and Nutrition (SIGENP)

Authors :
Martina Mainetti
Simona Gatti
Ester Giaquinto
Sergio Amarri
Antonella Lezo
Laura Lacitignola
Maria Immacolata Spagnuolo
Maristella Pellegrino
Martina Fornaro
Maria Elisabetta Baldassarre
Maria Luisa Forchielli
B. Parma
Lorenzo Norsa
Paolo Gandullia
Irina Goreva
Marcello Lanari
Elisa Ravaioli
Teresa Capriati
Nicola Cecchi
Valeria Dipasquale
Grazia Di Leo
Silvia Salvatore
Antonella Diamanti
Elvira Verduci
Valentina Fiorito
Lezo, Antonella
Capriati, Teresa
Spagnuolo, Maria Immacolata
Lacitignola, Laura
Goreva, Irina
Di Leo, Grazia
Cecchi, Nicola
Gandullia, Paolo
Amarri, Sergio
Forchielli, Maria Luisa
Dipasquale, Valeria
Parma, Barbara
Gatti, Simona
Ravaioli, Elisa
Salvatore, Silvia
Mainetti, Martina
Norsa, Lorenzo
Pellegrino, Maristella
Fornaro, Martina
Fiorito, Valentina
Lanari, Marcello
Giaquinto, Ester
Verduci, Elvira
Baldassarre, Maria Elisabetta
Diamanti, Antonella
Source :
Nutrients, Vol 10, Iss 9, p 1311 (2018), Nutrients, Volume 10, Issue 9
Publication Year :
2018
Publisher :
MDPI AG, 2018.

Abstract

Home Artificial Nutrition (HAN) is a safe and efficacious technique that insures children&rsquo<br />s reintegration into the family, society and school. Epidemiological data on paediatric HAN in Italy are not available. Aim: to detect the prevalence and incidence of Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN), either via tube or mouth, in Italy in 2016. Materials and methods: a specific form was sent to all registered SIGENP members and investigators of local HAN centres, inviting them to provide the requested centre&rsquo<br />s data and demographics, underlying diseases and HAN characteristics of the patients. Results: we recorded 3403 Italian patients on HAN aged 0 to 19 years from 22 centres: 2277 HEN, 950 Oral Nutritional Supplements (ONS) and 179 HPN programs. The prevalence of HEN (205 pts/million inhabitants) and HPN (16 pts/million inhabitants) has dramatically increased in Italy in the last 9 years. Neurodisabling conditions were the first indication for HEN by tube or mouth while HPN is mainly requested in digestive disorders. Conclusions: HAN is a widespread and rapidly growing treatment in Italy, as well as in other European countries. Awareness of its extent and characteristics helps improving HAN service and patients&rsquo<br />quality of life.

Details

ISSN :
20726643
Volume :
10
Database :
OpenAIRE
Journal :
Nutrients
Accession number :
edsair.doi.dedup.....cdb611e9d8fbef351689f8a6fb5d5f5e
Full Text :
https://doi.org/10.3390/nu10091311